Innovation and business strategy
Filter results by
Search HelpKeyword(s)
Survey or statistical program
Results
All (10)
All (10) ((10 results))
- Articles and reports: 88F0006X2007007Description:
Results from the Survey of Innovation 2003 raised some interesting questions. First, an unexpected one-third of establishments in R&D services were not innovative. According to the guidelines of the Oslo Manual, innovative establishments are those that introduced a new or significantly improved product or process on to the market or into production, within a specified interval. Second, many of these non-innovative establishments indicated that satisfying existing customers was irrelevant to their firms success. This was very different response from all other types of firms.
This working paper provides a potential explanation of these unexpected results, as well as an overview of available information on establishments in R&D services (NAICS 5417) in the context of professional services generally. The paper assembles descriptive data to show that non-innovative establishments in R&D services differ significantly from other non-innovative establishments and, while not innovative, they are nevertheless highly inventive. It presents some evidence to suggest that they are venture firms (firms relying on infusions of investment capital rather than revenues from sales to sustain their operations) and proposes a specific set of indicators that would facilitate resolution of the nature of firms in this industry group.
Release date: 2007-12-20 - Articles and reports: 88-003-X20040037427Geography: CanadaDescription:
A series of working papers on the transition from small to medium size is being derived from a joint project of Statistics Canada and the National Research Council's Industrial Research Assistance Program (NRC-IRAP). The project developed out of a need to better understand how and why certain businesses grow.
Release date: 2004-10-29 - 3. The transition from small to medium size: Industrial and geographic distribution of small high-growth firms ArchivedArticles and reports: 88-003-X20040037438Geography: CanadaDescription:
This analysis provides an estimate of the numbers of small companies that have, and have not, grown to medium size. It determines which industries and communities have the highest proportions of quickly growing small firms, where the firms that have not yet grown to medium size are, and how they could be supported in their growth strategy.
Release date: 2004-10-29 - Articles and reports: 88-003-X20040037440Geography: CanadaDescription:
Theories of business growth lead us to believe that, to grow, a company needs to be innovative, conduct research and development, have access to multiple sources of funding, protect its intellectual property, engage in alliances and establish itself in a market niche. In this article, interviews with Canadian technology-based companies show that some companies manage to grow by breaking these rules.
Release date: 2004-10-29 - 5. An Historical Comparison of Technological Change, 1998-2000 and 2000-2002, in the Private and Public Sectors ArchivedArticles and reports: 88F0006X2004007Description:
This paper presents data on technological change that have been made comparable from the Survey of Electronic Commerce and Technology (SECT) for 2000 and 2002. It shows that when comparable data for the 1998 to 2000 and 2000 to 2002 periods (based on the definition and survey universe employed by SECT 2000) are used, the propensity to adopt new technologies in the private sector has remained constant at about 40%. The rate of technology adoption in the public sector remained at four out of five organizations introducing significantly improved technologies (a level about twice as high as that for the private sector). This rate also shows little change from 2000. The paper presents the comparable technological change data, while explaining differences in the wording of the survey questions and universe between the two reference years. Information is provided for private and public sectors, selected employment size groups and sectors of both private and public sectors.
Release date: 2004-03-09 - Articles and reports: 88F0006X2003005Description:
The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2001 Biotechnology Use and Development Survey. Within the last few years, except for the amount of financing capital raised, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 358 in 1999 to 375 in 2001. The Human Health sector outpaces all the other sectors in terms of the number of firms, human resources, biotechnology revenues, biotechnology research and development expenditures, amount of financing capital raised, and the number of products in the pipeline. Contrary to medium-sized and large firms where the personnel is more homogenous, small firms employ mostly highly-qualified workers. The 2001 data show a maturing trend in small firms. Most firms could not hire enough people to fill all their vacancies (estimated at 953 positions in Canada) for the 2001 year.
Release date: 2003-03-28 - Articles and reports: 88-003-X20010035970Geography: CanadaDescription:
This article looks at the use of biotechnology, obstacles to commercialization and information sources on biotechnology.
Release date: 2001-10-31 - Articles and reports: 88-003-X20010035971Geography: CanadaDescription:
Biotechnology firms are generally flexible and innovative in their approaches to survival and growth in Canada and also on the world stage. Read an overview of some of the business strategies and practices used by biotechnology firms to conduct research and development and for some, commercialization of their products.
Release date: 2001-10-31 - Articles and reports: 88-003-X20010035972Geography: CanadaDescription:
Based on information from the 1997 Biotechnology Firm Survey, we know biotechnology firms generated $813 million in biotech revenues; employed 9,000 people in biotech-related activities and had almost 9,000 products across all stages of development. Explore issues such as - What are the main features of this sector? What is the extent of networking activities by the firms? And what kinds of problems are they facing when selling their products?
Release date: 2001-10-31 - Articles and reports: 88-003-X20000035770Geography: CanadaDescription:
Given the high cost of R&D, adopting the correct strategies and mix of products is required for success for Canadian biotechnology firms. A recent survey examined the rapid growth of 30 companies. Fast-growing enterprises adopted a strategy of patenting their products, avoiding major production delays, targeting export markets, accessing venture capital, conducting key alliances, and planning the IPO.
Release date: 2000-10-06
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (10)
Analysis (10) ((10 results))
- Articles and reports: 88F0006X2007007Description:
Results from the Survey of Innovation 2003 raised some interesting questions. First, an unexpected one-third of establishments in R&D services were not innovative. According to the guidelines of the Oslo Manual, innovative establishments are those that introduced a new or significantly improved product or process on to the market or into production, within a specified interval. Second, many of these non-innovative establishments indicated that satisfying existing customers was irrelevant to their firms success. This was very different response from all other types of firms.
This working paper provides a potential explanation of these unexpected results, as well as an overview of available information on establishments in R&D services (NAICS 5417) in the context of professional services generally. The paper assembles descriptive data to show that non-innovative establishments in R&D services differ significantly from other non-innovative establishments and, while not innovative, they are nevertheless highly inventive. It presents some evidence to suggest that they are venture firms (firms relying on infusions of investment capital rather than revenues from sales to sustain their operations) and proposes a specific set of indicators that would facilitate resolution of the nature of firms in this industry group.
Release date: 2007-12-20 - Articles and reports: 88-003-X20040037427Geography: CanadaDescription:
A series of working papers on the transition from small to medium size is being derived from a joint project of Statistics Canada and the National Research Council's Industrial Research Assistance Program (NRC-IRAP). The project developed out of a need to better understand how and why certain businesses grow.
Release date: 2004-10-29 - 3. The transition from small to medium size: Industrial and geographic distribution of small high-growth firms ArchivedArticles and reports: 88-003-X20040037438Geography: CanadaDescription:
This analysis provides an estimate of the numbers of small companies that have, and have not, grown to medium size. It determines which industries and communities have the highest proportions of quickly growing small firms, where the firms that have not yet grown to medium size are, and how they could be supported in their growth strategy.
Release date: 2004-10-29 - Articles and reports: 88-003-X20040037440Geography: CanadaDescription:
Theories of business growth lead us to believe that, to grow, a company needs to be innovative, conduct research and development, have access to multiple sources of funding, protect its intellectual property, engage in alliances and establish itself in a market niche. In this article, interviews with Canadian technology-based companies show that some companies manage to grow by breaking these rules.
Release date: 2004-10-29 - 5. An Historical Comparison of Technological Change, 1998-2000 and 2000-2002, in the Private and Public Sectors ArchivedArticles and reports: 88F0006X2004007Description:
This paper presents data on technological change that have been made comparable from the Survey of Electronic Commerce and Technology (SECT) for 2000 and 2002. It shows that when comparable data for the 1998 to 2000 and 2000 to 2002 periods (based on the definition and survey universe employed by SECT 2000) are used, the propensity to adopt new technologies in the private sector has remained constant at about 40%. The rate of technology adoption in the public sector remained at four out of five organizations introducing significantly improved technologies (a level about twice as high as that for the private sector). This rate also shows little change from 2000. The paper presents the comparable technological change data, while explaining differences in the wording of the survey questions and universe between the two reference years. Information is provided for private and public sectors, selected employment size groups and sectors of both private and public sectors.
Release date: 2004-03-09 - Articles and reports: 88F0006X2003005Description:
The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2001 Biotechnology Use and Development Survey. Within the last few years, except for the amount of financing capital raised, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 358 in 1999 to 375 in 2001. The Human Health sector outpaces all the other sectors in terms of the number of firms, human resources, biotechnology revenues, biotechnology research and development expenditures, amount of financing capital raised, and the number of products in the pipeline. Contrary to medium-sized and large firms where the personnel is more homogenous, small firms employ mostly highly-qualified workers. The 2001 data show a maturing trend in small firms. Most firms could not hire enough people to fill all their vacancies (estimated at 953 positions in Canada) for the 2001 year.
Release date: 2003-03-28 - Articles and reports: 88-003-X20010035970Geography: CanadaDescription:
This article looks at the use of biotechnology, obstacles to commercialization and information sources on biotechnology.
Release date: 2001-10-31 - Articles and reports: 88-003-X20010035971Geography: CanadaDescription:
Biotechnology firms are generally flexible and innovative in their approaches to survival and growth in Canada and also on the world stage. Read an overview of some of the business strategies and practices used by biotechnology firms to conduct research and development and for some, commercialization of their products.
Release date: 2001-10-31 - Articles and reports: 88-003-X20010035972Geography: CanadaDescription:
Based on information from the 1997 Biotechnology Firm Survey, we know biotechnology firms generated $813 million in biotech revenues; employed 9,000 people in biotech-related activities and had almost 9,000 products across all stages of development. Explore issues such as - What are the main features of this sector? What is the extent of networking activities by the firms? And what kinds of problems are they facing when selling their products?
Release date: 2001-10-31 - Articles and reports: 88-003-X20000035770Geography: CanadaDescription:
Given the high cost of R&D, adopting the correct strategies and mix of products is required for success for Canadian biotechnology firms. A recent survey examined the rapid growth of 30 companies. Fast-growing enterprises adopted a strategy of patenting their products, avoiding major production delays, targeting export markets, accessing venture capital, conducting key alliances, and planning the IPO.
Release date: 2000-10-06
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: